Development and validation of a risk scoring system to predict surgical-site infection after soft-tissue sarcoma resection

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1040220108

Enrollment

500

Registered

2022-12-23

Start date

2022-12-23

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Soft tissue sarcoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with STS who underwent surgical resection in Kanazawa University Hospital.

Exclusion criteria

Exclusion criteria: Patients with incomplete information regarding the clinical parameter or treatment of the patients.

Design outcomes

Primary

Measure	Time frame
The incidence of surgical site infection and its association with various factors were assessed. The associations of the clinical parameters, including age, diabetes, smoking during the previous year, tumor location, tumor depth, resected tumor size, operative time, skin graft or flap, preoperative chemotherapy, and radiation therapy, with surgical site infection are investigated	—

Secondary

Measure	Time frame
A scoring system for assessing the risk of SSI in each patient is developed by combining the risk factors.	—

Contacts

Public ContactShinji Miwa

Department of Orthopedic Surgery, Graduate School of Medical Science, Kanazawa University

miwapoti@yahoo.co.jp+81-762652374

Outcome results